A patient with confirmed multiple pulmonary emboli is experiencing increased anxiety, sharp chest pain, and tachycardia. When transitioning from nasal cannula to a non-rebreather mask, which nursing intervention is most critical to prevent further complications?

C) Monitor the patient's oxygen saturation continuously

A) Reassess the patient's blood pressure every 30 minutes

B) Position the patient flat on the bed to ensure comfort

C) Monitor the patient's oxygen saturation continuously

D) Administer a sedative to alleviate anxiety

A patient with confirmed multiple pulmonary emboli is experiencing worsening hypoxemia and right ventricular strain. What is the priority nursing intervention to address the patient's current condition?

C) Transition the patient to a non-rebreather mask and monitor vital signs closely.

A) Increase the flow rate of the nasal cannula oxygen.

B) Prepare the patient for immediate surgical embolectomy.

C) Transition the patient to a non-rebreather mask and monitor vital signs closely.

D) Administer additional intravenous fluids to manage hypotension.

A patient in the ICU is receiving intravenous heparin therapy for a confirmed thrombotic event but is showing signs of respiratory distress and hemodynamic instability. In assessing the patient’s current status, which nursing intervention is most critical to prioritize at this time?

D) Escalating to mechanical ventilatory support if needed

A) Administering supplemental oxygen via non-rebreather mask

B) Preparing for potential thrombolytic therapy initiation

C) Monitoring renal and hepatic function closely

D) Escalating to mechanical ventilatory support if needed

A patient in the ICU is receiving intravenous heparin for anticoagulation therapy but continues to exhibit signs of hemodynamic instability and respiratory distress. Based on the current clinical presentation and lab findings, which intervention should the nurse anticipate as a priority to address the patient's condition?

B) Prepare for the initiation of thrombolytic therapy to rapidly resolve the clot burden.

A) Administer a diuretic to reduce fluid overload and improve oxygenation.

B) Prepare for the initiation of thrombolytic therapy to rapidly resolve the clot burden.

C) Increase the flow rate of the non-rebreather mask to improve oxygen saturation.

D) Initiate chest physiotherapy to enhance pulmonary function and secretion clearance.

A nurse is caring for a patient with a pulmonary embolism who is receiving a heparin infusion and has just been started on thrombolytic therapy with tPA. The patient is showing signs of worsening respiratory distress. Which immediate nursing intervention is most appropriate to address the patient's current condition?

B) Prepare for intubation and mechanical ventilation

A) Increase the flow rate of oxygen delivery

B) Prepare for intubation and mechanical ventilation

C) Administer an additional dose of heparin

D) Place the patient in Trendelenburg position

A patient with a pulmonary embolism is experiencing worsening respiratory distress and altered mental status. The arterial blood gas analysis shows a pH of 7.28, PaCO2 of 52 mmHg, and PaO2 of 54 mmHg. Based on these findings, which intervention should the nurse prioritize to address the patient's current condition?

B) Prepare the patient for immediate endotracheal intubation.

A) Increase the flow rate of the non-rebreather mask to 15 L/min.

B) Prepare the patient for immediate endotracheal intubation.

C) Administer a bronchodilator to relieve respiratory distress.

D) Position the patient in high Fowler's position to facilitate breathing.

A patient undergoing thrombolytic therapy for a pulmonary embolism develops petechiae and mild oozing from intravenous sites. Which nursing intervention should be prioritized to address this complication?

C) Reduce the tPA infusion rate and monitor coagulation parameters.

A) Increase the infusion rate of intravenous fluids to manage hypotension.

B) Administer vitamin K to counteract the effects of thrombolytics.

C) Reduce the tPA infusion rate and monitor coagulation parameters.

D) Elevate the patient's legs to improve venous return.

A patient receiving thrombolytic therapy for a pulmonary embolism presents with petechiae and mild oozing from intravenous sites. The nurse notes that the patient's blood pressure is 88/56 mmHg, and arterial blood gas analysis shows a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 62 mmHg. What is the priority nursing action in this situation?

C) Reduce the tPA infusion rate and initiate supportive measures to manage bleeding.

A) Continue to monitor the patient's vital signs and coagulation parameters closely.

B) Increase the rate of the non-rebreather mask to improve oxygen saturation.

C) Reduce the tPA infusion rate and initiate supportive measures to manage bleeding.

D) Administer intravenous fluids to manage the patient's low blood pressure.

A patient in the critical care unit is experiencing persistent hypotension and new-onset tachycardia following thrombolytic therapy. Laboratory results show a drop in hemoglobin, decreased platelet count, and prolonged aPTT. What is the most appropriate initial nursing action to address this patient's current condition?

C) Increase the rate of intravenous fluids to stabilize the patient's hemodynamics.

A) Administer a vasopressor to increase blood pressure.

B) Prepare for a blood transfusion to address the low hemoglobin level.

C) Increase the rate of intravenous fluids to stabilize the patient's hemodynamics.

D) Contact the healthcare provider to discontinue the thrombolytic therapy immediately.

A patient undergoing thrombolytic therapy for an embolism develops hypotension, tachycardia, and a significant drop in hemoglobin and platelet counts. Which of the following interventions should the nurse prioritize to address the patient's hemodynamic instability?

C) Hold the thrombolytic therapy and prepare for possible blood transfusion

A) Administer intravenous fluids to increase circulating volume

B) Increase the infusion rate of thrombolytic therapy to resolve the embolism

C) Hold the thrombolytic therapy and prepare for possible blood transfusion

D) Administer a vasopressor to immediately raise blood pressure

Pulmonary embolism - Nursing Case Study

Pathophysiology

• Primary mechanism: A pulmonary embolism (PE) occurs when a blood clot, often originating from deep veins in the legs (deep vein thrombosis), travels to the pulmonary arteries, obstructing blood flow to lung tissue. This impairs gas exchange and can lead to hypoxemia, affecting oxygen delivery to the body.

• Secondary mechanism: The obstruction increases pulmonary vascular resistance, causing strain on the right side of the heart as it works harder to pump blood through the narrowed vessels. This can lead to right ventricular dysfunction or failure if the embolism is large or multiple clots are present.

• Key complication: Reduced cardiac output and severe hypoxemia can lead to systemic hypotension and shock, further complicating patient outcomes and requiring immediate management to restore hemodynamic stability and oxygenation.

Patient Profile

Demographics:

45-year-old male, construction worker

History:

• Key past medical history: Hypertension, deep vein thrombosis (DVT) 2 years ago

• Current medications: Lisinopril, warfarin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset of shortness of breath and chest pain

• Key symptoms: Shortness of breath, chest pain that worsens with deep breaths, coughing up blood, lightheadedness

• Vital signs: Blood pressure 145/95 mmHg, heart rate 110 bpm, respiratory rate 28 breaths per minute, oxygen saturation 88% on room air, temperature 99.1°F

Section 1

Change in Patient Status:

Shortly after the initial presentation, the patient’s condition began to deteriorate further. His oxygen saturation dropped to 82% despite supplemental oxygen via nasal cannula at 4 L/min, indicating a worsening hypoxemia. The patient became increasingly anxious and reported more severe chest pain, describing it as a sharp, stabbing sensation that intensified with each breath. This exacerbation of symptoms prompted the healthcare team to escalate care, transitioning the patient to a non-rebreather mask to improve oxygenation. Simultaneously, the patient developed new onset tachycardia with a heart rate spiking to 130 bpm, and his blood pressure fell to 100/65 mmHg, suggesting a potential progression towards hemodynamic instability.

In response to these alarming changes, the medical team conducted a thorough re-evaluation. An urgent CT pulmonary angiogram was ordered, which confirmed the presence of multiple pulmonary emboli, indicating a significant clot burden. Additionally, an echocardiogram was performed, revealing right ventricular dilation and dysfunction, consistent with acute strain due to increased pulmonary vascular resistance. These findings underscored the severity of the embolic event and the resultant strain on the cardiac system. The patient's clinical picture pointed towards the development of acute cor pulmonale, a complication that required immediate and aggressive management to prevent further decline.

The healthcare team initiated anticoagulation therapy with intravenous heparin to prevent further clot formation and considered thrombolytic therapy to rapidly dissolve the existing clots, given the patient's escalating symptoms and evidence of right heart strain. The decision was made to admit the patient to the intensive care unit for close monitoring and advanced support, recognizing the need for vigilant observation and potential escalation of care to manage this critical phase of his condition effectively. The multidisciplinary team prepared for potential interventions, such as mechanical support or surgical embolectomy, should the patient's status continue to decline despite initial management efforts.

Section 2

As the patient settled into the intensive care unit, the healthcare team remained vigilant in monitoring his response to the initiated interventions. Despite the anticoagulation therapy with intravenous heparin, the patient's condition did not show immediate improvement. His heart rate remained elevated at around 125 bpm, and his blood pressure was persistently low, hovering at 95/60 mmHg, suggesting ongoing hemodynamic compromise. Additionally, the patient's respiratory status was tenuous; although his oxygen saturation improved slightly to 86% with the non-rebreather mask, he continued to exhibit signs of respiratory distress, including shallow, rapid breathing at 30 breaths per minute and pronounced use of accessory muscles.

Lab results returned, showing a significantly elevated D-dimer level, further confirming the presence of thrombotic activity. Arterial blood gas analysis revealed a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 60 mmHg, indicative of respiratory acidosis with hypoxemia, reflecting the inadequate gas exchange due to compromised pulmonary perfusion. These findings prompted the critical care team to reassess the therapeutic strategy, considering the potential need for thrombolytic therapy to address the significant clot burden and alleviate the right heart strain.

In light of these developments, the team discussed potential complications such as hemorrhagic risk associated with thrombolysis and weighed them against the benefits of rapidly restoring pulmonary circulation. Plans were also made to closely monitor renal and hepatic function, as organ perfusion might be compromised in the context of systemic hypotension. The patient was placed on continuous telemetry to detect any arrhythmias due to the ongoing cardiac strain. The care team prepared for possible escalation to mechanical ventilatory support, should the patient's respiratory function continue to decline, while maintaining readiness for advanced interventions, including surgical embolectomy, if necessary.

Section 3

As the healthcare team continued to monitor the patient's condition, a change in his status became apparent. Despite the ongoing heparin infusion, the patient exhibited signs of worsening respiratory distress. His respiratory rate increased to 36 breaths per minute, and his use of accessory muscles became more pronounced. His oxygen saturation, which had slightly improved, started to decline again, dropping to 82% even with the non-rebreather mask. Increased anxiety and restlessness suggested escalating hypoxemia, prompting the team to escalate the level of respiratory support.

A repeat arterial blood gas analysis revealed further deterioration: the pH had decreased to 7.28, the PaCO2 had risen to 52 mmHg, and the PaO2 had fallen to 54 mmHg, indicating worsening respiratory acidosis and hypoxemia. These changes suggested that the pulmonary embolism was significantly compromising gas exchange. Simultaneously, the patient began to exhibit signs of altered mental status, including confusion and difficulty following commands, likely due to decreased cerebral oxygenation.

Given the patient's declining respiratory and neurological status, the decision was made to proceed with thrombolytic therapy, despite the associated risks. The team initiated a low-dose infusion of tissue plasminogen activator (tPA), while closely monitoring for signs of hemorrhagic complications. The patient was also prepped for potential intubation and mechanical ventilation to stabilize his respiratory function. The critical care team remained vigilant, ready to manage any immediate complications and continue reassessing the patient's response to the adjusted therapeutic strategy.

Section 4

As the thrombolytic therapy progressed, the healthcare team observed initial stabilization in the patient’s respiratory status. Over the next few hours, his oxygen saturation improved marginally to 85% with continued use of the non-rebreather mask, and his respiratory rate decreased to 28 breaths per minute. Despite these encouraging signs, the patient remained restless and continued to exhibit confusion, suggesting persistent cerebral hypoxemia. The critical care team remained concerned about the potential for further complications, particularly given the risks associated with tPA administration.

A repeat arterial blood gas analysis was conducted to assess the effectiveness of the thrombolytic therapy. The results showed some improvement: the pH had increased to 7.32, PaCO2 was slightly reduced to 48 mmHg, and PaO2 improved to 62 mmHg. While these changes indicated a positive response to the intervention, they also highlighted that the patient was not yet out of danger. His blood pressure had decreased to 88/56 mmHg, raising concerns about possible systemic hypotension, which could be a consequence of both the pulmonary embolism and the thrombolytic therapy.

As the team continued to monitor the patient, they noted a new complication: the development of petechiae and mild oozing from the intravenous sites, suggesting a bleeding tendency. This was a concerning development, as it could signify a hemorrhagic complication from the thrombolytics. The team immediately reduced the tPA infusion rate and initiated supportive measures to address the bleeding, while closely monitoring coagulation parameters such as the activated partial thromboplastin time (aPTT) and platelet count. The balance between treating the life-threatening embolism and managing the risk of bleeding required careful clinical reasoning and constant reassessment to guide further interventions.

Section 5

As the critical care team continued to manage the situation, they observed a change in the patient's status that warranted immediate attention. Despite the earlier reduction in the tPA infusion rate, the patient’s blood pressure remained low, now measuring at 86/54 mmHg. This persistent hypotension, coupled with the new onset of tachycardia with a heart rate of 122 beats per minute, suggested the development of hemodynamic instability. The team suspected that the patient might be experiencing a systemic response to the embolism or a potential complication from the thrombolytic therapy, such as a bleeding-related reduction in circulating volume.

Laboratory results further contributed to the team's concern. The latest complete blood count indicated a drop in hemoglobin to 9.2 g/dL and a decrease in platelet count to 105,000/mm³. Additionally, the aPTT was elevated at 92 seconds, confirming a prolonged coagulation status. These findings reinforced the suspicion of a bleeding complication, possibly exacerbated by the thrombolytic treatment. Clinically, the patient appeared pale and continued to exhibit signs of restlessness and confusion, indicating that cerebral hypoxemia might still be a pressing issue despite the ongoing interventions.

In response to these developments, the critical care team initiated a multifaceted approach. They prepared for potential blood transfusion to address the decreasing hemoglobin levels and considered the administration of intravenous fluids to support blood pressure stabilization. The team also arranged for a consult with the hematology service to evaluate the bleeding risk and guide adjustments in the management of anticoagulation therapy. As the team balanced these complex considerations, they remained vigilant in their monitoring, recognizing the delicate interplay between resolving the embolism and mitigating the emerging complications.